# NAMENDA XR
> **NDA022525** · New Drug Application · Sponsor: ABBVIE · Approved 2010-06-21
## Drug
- **FDA Application Number:** NDA022525
- **Application type:** New Drug Application
- **Brand name:** NAMENDA XR
- **Generic name:** Memantine Hydrochloride
- **Active ingredients:** MEMANTINE HYDROCHLORIDE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ABBVIE
- **First approval:** 2010-06-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022525)
---
*AI Analytics · CC0 1.0*